$82.38 -0.61 (%) Express Scripts Holding Co - NASDAQ

Mar. 27, 2015 | 04:00 PM

Partner Headlines

  1. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  2. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD | Feb. 27, 2015 | 11:48AM EST
  3. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD | Feb. 26, 2015 | 11:59AM EST
  4. 10 Stocks You Should Be Watching Today

    Benzinga | Feb. 24, 2015 | 04:21AM EST
  5. EXPRESS SCRIPTS

    IBD | Feb. 23, 2015 | 18:33PM EST
  6. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After Hours

    Benzinga | Feb. 23, 2015 | 17:25PM EST
  7. Nasdaq Stretches Win Streak To 9 Days

    IBD | Feb. 23, 2015 | 17:03PM EST
  8. Earnings Scheduled For February 23, 2015

    Benzinga | Feb. 23, 2015 | 05:03AM EST
  9. Must Watch Stocks for Today

    Benzinga | Feb. 23, 2015 | 04:01AM EST
  10. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD | Feb. 20, 2015 | 16:58PM EST
  11. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus | Feb. 18, 2015 | 18:25PM EST
  12. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus | Feb. 13, 2015 | 16:01PM EST
  13. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus | Feb. 13, 2015 | 13:00PM EST
  14. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD | Feb. 11, 2015 | 17:50PM EST
  15. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

    GuruFocus | Feb. 6, 2015 | 10:59AM EST
  16. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus | Feb. 4, 2015 | 11:24AM EST
  17. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD | Feb. 3, 2015 | 19:26PM EST
  18. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga | Jan. 29, 2015 | 14:18PM EST
  19. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum And Express Scripts

    Benzinga | Jan. 29, 2015 | 06:57AM EST
  20. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  21. Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

    GuruFocus | Jan. 22, 2015 | 12:32PM EST
  22. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD | Jan. 21, 2015 | 12:55PM EST
  23. Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year

    Benzinga | Jan. 20, 2015 | 16:21PM EST
  24. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD | Jan. 16, 2015 | 15:43PM EST
  25. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga | Jan. 15, 2015 | 11:14AM EST
  26. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus | Jan. 13, 2015 | 19:10PM EST
  27. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  28. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  29. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus | Jan. 13, 2015 | 14:55PM EST
  30. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  31. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  32. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  33. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus | Jan. 6, 2015 | 12:22PM EST
  34. Hepatitis Drugs Vie For Share

    IBD | Jan. 5, 2015 | 18:44PM EST
  35. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD | Jan. 5, 2015 | 18:21PM EST
  36. Stocks Lose More Ground; Gilead Sciences Rises

    IBD | Jan. 5, 2015 | 15:10PM EST
  37. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD | Jan. 5, 2015 | 15:09PM EST
  38. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD | Jan. 2, 2015 | 18:13PM EST
  39. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga | Jan. 2, 2015 | 09:36AM EST
  40. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  41. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD | Dec. 29, 2014 | 11:59AM EST
  42. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD | Dec. 27, 2014 | 08:02AM EST
  43. IBD 50: Biotechs Hammered, Then Find Support

    IBD | Dec. 26, 2014 | 18:27PM EST
  44. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases in Value by 35%

    GuruFocus | Dec. 26, 2014 | 17:44PM EST
  45. Biotech Stocks Take A Beating, But Find Support

    IBD | Dec. 24, 2014 | 16:56PM EST
  46. Stocks Score Small Gains; Virgin America Takes Flight

    IBD | Dec. 24, 2014 | 11:57AM EST
  47. How Gilead And Johnson & Johnson's Tumble Affected These Hedge Funds

    Benzinga | Dec. 24, 2014 | 11:27AM EST
  48. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis Pact

    Benzinga | Dec. 23, 2014 | 16:13PM EST
  49. Toys, Department Stores Rock, But Biotechs Tumble

    IBD | Dec. 23, 2014 | 12:06PM EST
  50. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price War'

    Benzinga | Dec. 23, 2014 | 10:56AM EST
Trading Center